Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Jori S, Carter"'
Publikováno v:
Brachytherapy. 18:29-37
Stage and histology are well-established prognostic factors for cervical cancer, but the importance of age has been controversial and a clear role for this factor has not yet been defined. Thus, we aim with this study to evaluate the significance of
Autor:
Emma C. Fields, Lisa A. Rubinsak, Sarah M. Temkin, Jori S. Carter, Le Kang, William P. McGuire
Publikováno v:
International Journal of Gynecologic Cancer. 28:1387-1393
ObjectiveThe purpose of this study is to identify incidence of and factors associated with severe late toxicity in women treated with radiation for cervical cancer.Materials and MethodsAll patients with cervical cancer treated with radiation as prima
Autor:
John Chuckalovcak, Jori S. Carter, Jane L. Roberts, Mehrad Tavallai, Aida Nourbakhsh, Andrew Poklepovic, Laurence Booth, Paul Dent
Publikováno v:
Journal of Cellular Physiology
We examined the interaction between OSU‐03012 (also called AR‐12) with phosphodiesterase 5 (PDE5) inhibitors to determine the role of the chaperone glucose‐regulated protein (GRP78)/BiP/HSPA5 in the cellular response. Sildenafil (Viagra) intera
Autor:
Joseph S. Koopmeiners, Levi S. Downs, Patrick J. Bolan, Jessica E Kuehn-Hajder, Gregory J. Metzger, Navneeth Lakkadi, Jori S. Carter
Publikováno v:
Journal of Magnetic Resonance Imaging. 38:1501-1509
Purpose To identify parameters associated with ovarian malignancy using multiparametric quantitative magnetic resonance imaging (MRI). Materials and Methods After Institutional Review Board (IRB) approval, women with ovarian masses underwent preopera
Autor:
Levi S. Downs, Susanta K. Hui, Jori S. Carter, Patrick J. Bolan, Yan Zhang, Douglas Yee, Thanasak Sueblinvong, Jerry W. Froelich, Steen Moeller, Luke Arentsen, Rahel G Ghebre
Publikováno v:
Journal of Magnetic Resonance Imaging. 38:1578-1584
Purpose To assess the feasibility of using fat-fraction imaging for measuring marrow composition changes over large regions in patients undergoing cancer therapy.
Autor:
Jori S. Carter, Levi S. Downs
Publikováno v:
Obstetrics and Gynecology Clinics of North America. 39:213-231
Vulvar cancer is becoming more common as the population ages and is primarily a disease of the elderly. Most vulvar cancers are diagnosed at a localized stage and can be cured with surgery and adjuvant radiotherapy. More conservative therapy has been
Publikováno v:
Journal of Clinical Oncology. 36:e22072-e22072
e22072Background: Studies describing patient factors associated with radiation toxicity in cervical cancer (CxCa) treatment predate advancements in the delivery of radiotherapy. This study identifi...
Autor:
Timothy Webb, Andrew Poklepovic, Laurence Booth, Jori S. Carter, William P. McGuire, Paul Dent, Jane L. Roberts
The present studies sought to determine whether the lethality of the drug combination [sorafenib + sildenafil] could be enhanced by the anti-inflammatory agent celecoxib, using ovarian cancer and other tumor cell lines as models. Also, in a dose depe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0cc6b5f502c58de2a71062ca4b5df3d
https://europepmc.org/articles/PMC4846137/
https://europepmc.org/articles/PMC4846137/
Publikováno v:
Gynecologic Oncology Case Reports
Intraperitoneal (IP) chemotherapy has a proven survival advantage in patients with optimally cytoreduced advanced epithelial ovarian cancer (Armstrong et al., 2006). Placement of IP catheters can be performed at the time of optimal cytoreductive surg